| Segment and Geographic Information |
The Company operates
a single segment business for product revenues, which consists of three geographical sales territories as follows:
| |
|
Three Months |
|
|
Six Months |
|
| |
|
Ended |
|
|
Ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Geographic region |
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
| United States |
|
$ |
1,186,000 |
|
|
$ |
356,000 |
|
|
$ |
1,973,000 |
|
|
$ |
711,000 |
|
| Latin America |
|
|
1,266,000 |
|
|
|
1,167,000 |
|
|
|
2,824,000 |
|
|
|
2,260,000 |
|
| Europe and Rest of World |
|
|
952,000 |
|
|
|
553,000 |
|
|
|
1,523,000 |
|
|
|
1,226,000 |
|
| |
|
|
3,404,000 |
|
|
|
2,076,000 |
|
|
|
6,320,000 |
|
|
|
4,197,000 |
|
| Product license fees and royalties |
|
|
339,000 |
|
|
|
997,000 |
|
|
|
786,000 |
|
|
|
2,046,000 |
|
| Total product related revenues |
|
$ |
3,743,000 |
|
|
$ |
3,073,000 |
|
|
|
7,106,000 |
|
|
|
6,243,000 |
|
The following table shows the Company’s
product license fees and royalties revenues by partner:
| |
|
Three Months |
|
|
Six Months |
|
| |
|
Ended |
|
|
Ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Partner |
|
2015 |
|
|
2014 |
|
|
2015 |
|
|
2014 |
|
| Exeltis (formerly Quinnova) |
|
$ |
103,000 |
|
|
$ |
161,000 |
|
|
$ |
157,000 |
|
|
$ |
307,000 |
|
| Innovacyn |
|
|
9,000 |
|
|
|
459,000 |
|
|
|
29,000 |
|
|
|
987,000 |
|
| Laboratorios Sanfer (formerly More Pharma) |
|
|
227,000 |
|
|
|
377,000 |
|
|
|
600,000 |
|
|
|
752,000 |
|
| Total product license fees and royalties |
|
$ |
339,000 |
|
|
$ |
997,000 |
|
|
|
786,000 |
|
|
|
2,046,000 |
|
|